- Home
- ADAG vs SST Comparison
ADAG vs SST Comparison
Compare ADAG & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- SST
- Stock Information
- Founded
- ADAG 2011
- SST 2013
- Country
- ADAG China
- SST United States
- Employees
- ADAG N/A
- SST N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- SST Diversified Commercial Services
- Sector
- ADAG Health Care
- SST Consumer Discretionary
- Exchange
- ADAG Nasdaq
- SST Nasdaq
- Market Cap
- ADAG 84.4M
- SST 67.7M
- IPO Year
- ADAG 2021
- SST N/A
- Fundamental
- Price
- ADAG $1.88
- SST $3.53
- Analyst Decision
- ADAG Strong Buy
- SST Strong Buy
- Analyst Count
- ADAG 3
- SST 1
- Target Price
- ADAG $7.67
- SST $10.00
- AVG Volume (30 Days)
- ADAG 82.0K
- SST 24.3K
- Earning Date
- ADAG 08-12-2025
- SST 11-05-2025
- Dividend Yield
- ADAG N/A
- SST N/A
- EPS Growth
- ADAG N/A
- SST N/A
- EPS
- ADAG N/A
- SST N/A
- Revenue
- ADAG $103,204.00
- SST $289,784,000.00
- Revenue This Year
- ADAG $7,411.34
- SST N/A
- Revenue Next Year
- ADAG $28.29
- SST $12.20
- P/E Ratio
- ADAG N/A
- SST N/A
- Revenue Growth
- ADAG N/A
- SST N/A
- 52 Week Low
- ADAG $1.30
- SST $2.90
- 52 Week High
- ADAG $3.16
- SST $15.00
- Technical
- Relative Strength Index (RSI)
- ADAG 53.39
- SST 22.11
- Support Level
- ADAG $1.44
- SST $4.35
- Resistance Level
- ADAG $1.96
- SST $4.95
- Average True Range (ATR)
- ADAG 0.19
- SST 0.43
- MACD
- ADAG 0.02
- SST -0.16
- Stochastic Oscillator
- ADAG 71.12
- SST 1.30
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.